Tower Research Capital LLC (Trc) Relmada Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.93 - $4.94 $20,515 - $34,589	-7,002 Reduced 71.77%	2,754 $8,000
Q1 2024 May 15, 2024	BUY	$3.1 - $6.8 $22,651 - $49,687	7,307 Added 298.37%	9,756 $45,000
Q4 2023 Feb 13, 2024	BUY	$2.45 - $4.22 $1,810 - $3,118	739 Added 43.22%	2,449 $10,000
Q3 2023 Nov 14, 2023	SELL	$2.48 - $3.79 $7,705 - $11,775	-3,107 Reduced 64.5%	1,710 $5,000
Q2 2023 Aug 14, 2023	BUY	$2.22 - $3.54 $439 - $700	198 Added 4.29%	4,817 $11,000
Q1 2023 May 09, 2023	SELL	$2.24 - $4.76 $43,505 - $92,448	-19,422 Reduced 80.79%	4,619 $10,000
Q4 2022 Feb 10, 2023	BUY	$2.17 - $35.84 $50,320 - $831,093	23,189 Added 2721.71%	24,041 $84,000
Q3 2022 Nov 10, 2022	SELL	$18.3 - $37.02 $11,291 - $22,841	-617 Reduced 42.0%	852 $32,000
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $20,806 - $38,258	1,261 Added 606.25%	1,469 $28,000
Q1 2022 May 12, 2022	SELL	$16.72 - $26.99 $17,037 - $27,502	-1,019 Reduced 83.05%	208 $6,000
Q4 2021 Feb 14, 2022	BUY	$16.93 - $26.82 $9,243 - $14,643	546 Added 80.18%	1,227 $28,000
Q3 2021 Nov 15, 2021	SELL	$21.86 - $34.77 $7,869 - $12,517	-360 Reduced 34.58%	681 $18,000
Q2 2021 Aug 16, 2021	SELL	$29.55 - $39.15 $22,369 - $29,636	-757 Reduced 42.1%	1,041 $33,000
Q1 2021 May 17, 2021	BUY	$31.52 - $39.28 $19,542 - $24,353	620 Added 52.63%	1,798 $63,000
Q4 2020 Feb 16, 2021	SELL	$29.88 - $39.8 $331,787 - $441,939	-11,104 Reduced 90.41%	1,178 $37,000
Q3 2020 Nov 16, 2020	BUY	$34.42 - $43.78 $391,734 - $498,260	11,381 Added 1263.15%	12,282 $462,000
Q2 2020 Aug 13, 2020	BUY	$31.59 - $49.98 $28,462 - $45,031	901 New	901 $40,000
Q1 2020 May 15, 2020	SELL	$23.78 - $50.12 $50,960 - $107,407	-2,143 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$10.1 - $47.18 $21,644 - $101,106	2,143 New	2,143 $84,000

Others Institutions Holding RLMD

# of Institutions

Shares Held

12.3M

Call Options Held

229K

Put Options Held

138K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account